Psyomics

Psyomics Ltd is a health-tech and biotechnology company based in Cambridge, UK, founded in 2015 as a spinout from the University of Cambridge's Bahn lab. The company specializes in precision mental health solutions aimed at improving the diagnosis, assessment, triage, and treatment of psychiatric disorders. Led by CEO Dr. Melinda Rees, Psyomics develops clinically-led digital tools and biomarkers to enhance mental health access and outcomes, addressing challenges faced by systems like the NHS. Psyomics offers innovative digital platforms, including the beseen™ platform, which streamlines mental health intake through structured questionnaires and holistic patient histories. The platform has variants for adults, young people, and neurodiversity, ensuring tailored care. Additionally, the Censeo platform facilitates efficient mental health assessments, while their biomarker tests combine digital and blood-based diagnostics for improved diagnosis of major disorders. Psyomics collaborates with various NHS trusts and private providers, expanding its reach to support thousands of lives.